ASCO 2012 Multiple Myeloma Update – Day Three: New Myeloma Treatments

Posted on June 4th, 2012 by

One of the morning presentations was given by Dr. Melissa Alsina from the H. Lee Moffitt Cancer Center in Tampa, Florida.  Dr. Alsina presented a Phase 2 study of panobinostat in combination with Velcade (bortezomib) and dexamethasone (Decadron)… The panobinostat trial results were reviewed by Dr. Asher Chanan-Khan of the Mayo Clinic in Jacksonville, Florida, in a presentation that also took place during this morning’s session.

 

Myeloma Beacon

Tags: Cancer, Dr. Asher Chanan-Khan, Dr. Melissa Alsina, Facilities, H. Lee Moffitt Cancer Center, Mayo Clinic Jacksonville, multiple myeloma, Myeloma Beacon, Preventive Medicine, Research

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy